Alessandro Di Lisi, Leuci Emanuela, Quattrone Emanuela, Azzali Silvia, Paulillo Giuseppina, Pupo Simona, Pellegrini Pietro, Marco Menchetti, Lorenzo Pelizza
Department of Biomedical and Neuromotor Sciences, Alma Mater Studiorum Università di Bologna, Viale Pepoli 5, 40126 Bologna, Italy.
Department of Mental Health and Pathological Addictions, AUSL di Parma, Largo Palli n. 1/a, 43100 Parma, Italy.
Schizophr Res. 2024 Dec;274:11-20. doi: 10.1016/j.schres.2024.09.005. Epub 2024 Sep 7.
Aim - Recent findings suggest that OCS are prevalent in individuals with early psychosis. However, their clinical relevance still needs to be clarified. This research specifically explored OCS in subjects at Clinical High Risk for Psychosis (CHRP), with the aims of determining their baseline prevalence, examining their 2-year stability, and analyzing their association with sociodemographic data, clinical characteristics and outcomes. Methods - Clinical assessments at baseline and during the 2-year follow-up period included: the Comprehensive Assessment of At-Risk Mental states (CAARMS), the Positive And Negative Syndrome Scale (PANSS), and the Global Assessment of Functioning (GAF). OCS were identified using the CAARMS item 7.6 subscore. Results - Among 180 CHR-P participants, 66 (36.7 %) had OCS at baseline. CHR-P with OCS had higher PANSS scores and greater antidepressant prescription rates. OCS severity levels improved in the first year, but plateaued over two years, correlating with longitudinal changes in GAF and PANSS total scores. OCS improvement was specifically associated with antidepressant use and intensity of individual psychotherapy sessions. CHR-P subjects with OCS had higher service engagement rates. Conclusions - The presence of OCS could characterize a distinct CHR-P subtype with specific clinical and prognostic characteristics, requiring tailored diagnostic and therapeutic approaches. Recognizing the heterogeneity in CHR-P population is crucial for optimizing care.
目的——近期研究结果表明,强迫症状在早期精神病患者中普遍存在。然而,其临床相关性仍有待阐明。本研究专门探讨了精神病临床高危人群(CHRP)中的强迫症状,旨在确定其基线患病率,检查其两年稳定性,并分析其与社会人口统计学数据、临床特征及转归的关联。方法——基线及两年随访期的临床评估包括:高危精神状态综合评估(CAARMS)、阳性与阴性症状量表(PANSS)及功能总体评定量表(GAF)。使用CAARMS第7.6项子评分确定强迫症状。结果——180名CHR-P参与者中,66人(36.7%)在基线时有强迫症状。有强迫症状的CHR-P参与者PANSS评分更高,抗抑郁药处方率更高。强迫症状严重程度在第一年有所改善,但在两年间趋于平稳,与GAF及PANSS总分的纵向变化相关。强迫症状的改善与抗抑郁药使用及个体心理治疗疗程强度具体相关。有强迫症状的CHR-P受试者服务参与率更高。结论——强迫症状的存在可能表征一种具有特定临床和预后特征的独特CHR-P亚型,需要量身定制诊断和治疗方法。认识到CHR-P人群的异质性对于优化治疗至关重要。